TY - JOUR
T1 - Type 1 diabetes in pre-school children - long-term metabolic control, associated autoimmunity and complications
AU - Levy-Shraga, Y.
AU - Lerner-Geva, L.
AU - Boyko, V.
AU - Graph-Barel, C.
AU - Mazor-Aronovitch, K.
AU - Modan-Moses, D.
AU - Pinhas-Hamiel, O.
PY - 2012/10
Y1 - 2012/10
N2 - Aims To identify clinical characteristics and co-morbidity rates of children diagnosed with Type 1 diabetes mellitus at younger than 6years of age. Methods Data were obtained from a retrospective chart review of 103 patients diagnosed with Type 1 diabetes at younger than 6years (study group) and 220 patients at older than 6years (comparison group). Measures of glycaemic control and occurrence of co-morbidities (coeliac disease, autoimmune thyroid disease, hypertension, nephropathy and retinopathy) were compared. Results The mean follow-up period was more than 8years. For the study group, mean HbA1c levels ranged from 64mmol/mol to 66mmol/mol (8.0-8.2%) until age 10years, and then rose to 73mmol/mol (8.8%). The HbA1c levels were higher in the study than in the comparison group for comparable ages (P=0.003). After adjustment for duration of diabetes this difference was not significant. The overall rate of severe hypoglycaemic events was greater in the study group than in the comparison group (P=0.03). Kaplan-Meier diagnosis rates of celiac disease, 10years after Type 1 diabetes diagnosis, were 14.4% and 4.2% in the study and comparison groups, respectively (P log-rank=0.03). There were no differences in rates of autoimmune thyroid disease, hypertension, nephropathy or retinopathy. Conclusions Children diagnosed with Type 1 diabetes before the age of 6years were in greater risk of developing celiac disease, compared with children diagnosed after the age of 6years. For children diagnosed with Type 1 diabetes aged under 6years, good metabolic control was achievable until age 10years, after which it deteriorated. Higher HbA1c levels observed in children diagnosed before the age of 6years were associated with longer duration of disease.
AB - Aims To identify clinical characteristics and co-morbidity rates of children diagnosed with Type 1 diabetes mellitus at younger than 6years of age. Methods Data were obtained from a retrospective chart review of 103 patients diagnosed with Type 1 diabetes at younger than 6years (study group) and 220 patients at older than 6years (comparison group). Measures of glycaemic control and occurrence of co-morbidities (coeliac disease, autoimmune thyroid disease, hypertension, nephropathy and retinopathy) were compared. Results The mean follow-up period was more than 8years. For the study group, mean HbA1c levels ranged from 64mmol/mol to 66mmol/mol (8.0-8.2%) until age 10years, and then rose to 73mmol/mol (8.8%). The HbA1c levels were higher in the study than in the comparison group for comparable ages (P=0.003). After adjustment for duration of diabetes this difference was not significant. The overall rate of severe hypoglycaemic events was greater in the study group than in the comparison group (P=0.03). Kaplan-Meier diagnosis rates of celiac disease, 10years after Type 1 diabetes diagnosis, were 14.4% and 4.2% in the study and comparison groups, respectively (P log-rank=0.03). There were no differences in rates of autoimmune thyroid disease, hypertension, nephropathy or retinopathy. Conclusions Children diagnosed with Type 1 diabetes before the age of 6years were in greater risk of developing celiac disease, compared with children diagnosed after the age of 6years. For children diagnosed with Type 1 diabetes aged under 6years, good metabolic control was achievable until age 10years, after which it deteriorated. Higher HbA1c levels observed in children diagnosed before the age of 6years were associated with longer duration of disease.
UR - http://www.scopus.com/inward/record.url?scp=84866438913&partnerID=8YFLogxK
U2 - 10.1111/j.1464-5491.2012.03682.x
DO - 10.1111/j.1464-5491.2012.03682.x
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 22507070
AN - SCOPUS:84866438913
SN - 0742-3071
VL - 29
SP - 1291
EP - 1296
JO - Diabetic Medicine
JF - Diabetic Medicine
IS - 10
ER -